1. Home
  2. EZGO vs CDT Comparison

EZGO vs CDT Comparison

Compare EZGO & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZGO
  • CDT
  • Stock Information
  • Founded
  • EZGO 2014
  • CDT 2019
  • Country
  • EZGO China
  • CDT United States
  • Employees
  • EZGO N/A
  • CDT N/A
  • Industry
  • EZGO Motor Vehicles
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZGO Consumer Discretionary
  • CDT Health Care
  • Exchange
  • EZGO Nasdaq
  • CDT Nasdaq
  • Market Cap
  • EZGO 2.0M
  • CDT 2.2M
  • IPO Year
  • EZGO 2021
  • CDT N/A
  • Fundamental
  • Price
  • EZGO $0.34
  • CDT $2.74
  • Analyst Decision
  • EZGO
  • CDT
  • Analyst Count
  • EZGO 0
  • CDT 0
  • Target Price
  • EZGO N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • EZGO 111.2K
  • CDT 725.7K
  • Earning Date
  • EZGO 01-17-2025
  • CDT 08-11-2025
  • Dividend Yield
  • EZGO N/A
  • CDT N/A
  • EPS Growth
  • EZGO N/A
  • CDT N/A
  • EPS
  • EZGO N/A
  • CDT N/A
  • Revenue
  • EZGO $21,134,425.00
  • CDT N/A
  • Revenue This Year
  • EZGO N/A
  • CDT N/A
  • Revenue Next Year
  • EZGO N/A
  • CDT N/A
  • P/E Ratio
  • EZGO N/A
  • CDT N/A
  • Revenue Growth
  • EZGO 32.75
  • CDT N/A
  • 52 Week Low
  • EZGO $0.29
  • CDT $2.21
  • 52 Week High
  • EZGO $1.91
  • CDT $1,844.85
  • Technical
  • Relative Strength Index (RSI)
  • EZGO 46.88
  • CDT 31.11
  • Support Level
  • EZGO $0.31
  • CDT $2.21
  • Resistance Level
  • EZGO $0.35
  • CDT $2.58
  • Average True Range (ATR)
  • EZGO 0.02
  • CDT 0.19
  • MACD
  • EZGO -0.00
  • CDT 0.23
  • Stochastic Oscillator
  • EZGO 46.97
  • CDT 54.45

About EZGO EZGO Technologies Ltd.

EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: